LXRX
Lexicon Pharmaceuticals Inc
Price:  
2.39 
USD
Volume:  
3,136,448.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

LXRX WACC - Weighted Average Cost of Capital

The WACC of Lexicon Pharmaceuticals Inc (LXRX) is 7.9%.

The Cost of Equity of Lexicon Pharmaceuticals Inc (LXRX) is 8.25%.
The Cost of Debt of Lexicon Pharmaceuticals Inc (LXRX) is 7.00%.

Range Selected
Cost of equity 6.90% - 9.60% 8.25%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 7.00% - 7.00% 7.00%
WACC 6.7% - 9.1% 7.9%
WACC

LXRX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.66 0.85
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.90% 9.60%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.14 0.14
Cost of debt 7.00% 7.00%
After-tax WACC 6.7% 9.1%
Selected WACC 7.9%